Navigation Links
CHPA Responds to Kentucky Senate Judiciary Passage of Senate Bill 3
Date:3/1/2012

WASHINGTON, March 1, 2012 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) released the following statement after the Kentucky Senate Judiciary Committee passed Senate Bill 3, legislation that would impose significant restrictions on safe and effective medicines containing pseudoephedrine (PSE), such as Advil Cold & Sinus, Allegra-D, Claritin-D, Mucinex D, and Sudafed.  SB 3 would limit the amount of PSE consumers can buy to 15 grams a year and 3.6 grams a month. The measure now moves to the full Senate for consideration.  

"Severe restrictions on cold and allergy medicines containing pseudoephedrine will prevent chronic allergy suffers and many Kentucky families from accessing affordable, quality healthcare they rely upon," said Scott Melville, president and chief executive officer of the CHPA. "For thousands of Kentuckians—especially those who suffer from seasonal allergy symptoms—there's absolutely no difference between a prescription mandate and Senate Bill 3, especially given the fact that the Commonwealth of Kentucky has one of the longest allergy seasons in the country. The significant gram limit called for in SB 3 would lead to involuntary time off work, lost wages and increased health expenses for many responsible Kentucky families and workers."

"Kentucky Senators made the right decision when they shut the door on SB 50 last week. We are hopeful that the Kentucky Senate will listen to their constituents and enact anti-meth policies that target criminals without burdening responsible workers and families with additional barriers to these legal medicines."

www.chpa-info.org

CHPA is the 131-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. CHPA Responds to Prescription Mandate Cost Implications Outlined in Oklahoma Economic Impact Study
2. Questcor Pharmaceuticals Responds to Questions From Investor Blog
3. AVMA Responds to Federal Order Limiting Use of Antibiotics In Food Animals
4. Ampio Responds to Recent Publications by Anonymous Short Sellers
5. Nationwide Coalition Responds to Express Scripts CEO Statement: "I Cant Stop Certain Pharmacies From Going Out of Business"
6. China Medical Technologies Responds to the Allegations Raised by Glaucus Research Group
7. International Academy of Compounding Pharmacists (IACP) Responds to FDAs Appeal of the U.S. District Court Ruling on Pharmacy Compounding
8. Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its ANTISENILIN® Alzheimers Patent Application
9. NeuroSigma Responds to Substantial Interest Generated by NPR Story on Promising Epilepsy Clinical Trial
10. Cellestis Responds to World Health Organization Guidance on Use of Blood Tests for Active Tuberculosis
11. Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of ACTOS (pioglitazone HCl)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Research and Markets has announced the addition of ... to their offering. ... provides separate comprehensive analytics for the US, Canada , ... Asia-Pacific , and Rest of World. Annual estimates and forecasts are ... is provided for these markets. Market data and analytics are derived from ...
(Date:2/17/2017)... AMSTERDAM , Feb. 17, ... connected health offerings at the  ...  (NYSE: PHG,AEX: PHIA), a global ... a broad range of population ... personal health solutions, fully integrated in a ...
(Date:2/16/2017)... 16, 2017 Research and Markets has ... Medical Device Technologies" report to their offering. ... Traditional medical ... general instruments, non-drug coated implantables, large endoscopes, needle based drug ... over the last two to three decades for the treatment ...
Breaking Medicine Technology:
(Date:2/18/2017)... ... ... Park Cities Pet Sitter President, Joette White, has been featured on Episode ... The episode, which was posted this week, features a 30-minute interview of White by ... Pet Sitter’s being awarded the 2017 National Association of Professional Pet Sitter’s Business of ...
(Date:2/17/2017)... ... February 17, 2017 , ... The ... systems change designed to further positively impact the health and wellness of our ... long considered it our duty to seriously consider releasing our assets beyond our ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... Steps to Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 — ... Do manufacturers distinguish between corrective action (CA) and preventive action (PA)? , The ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended CHI's 8th ... of clinical trial planning and management. Pharmica discussed the importance of effective project ... attendees stopping by Pharmica’s booth were able to demo its cloud-based Resource ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Mason Pasquin Agency, ... and business owners in and around the Hampton Roads metropolitan region, is joining ... forms of domestic violence. , There are multiple categories of domestic violence – ...
Breaking Medicine News(10 mins):